Can Expanding Contraceptive Access Reduce Adverse Infant Health Outcomes?

48 Pages Posted: 14 Apr 2023 Last revised: 8 Mar 2024

See all articles by James Flynn

James Flynn

Miami University of Ohio - Richard T. Farmer School of Business Administration

Multiple version iconThere are 2 versions of this paper

Date Written: October 19, 2023

Abstract

This paper uses the rollout of a privately funded family planning program in Colorado to demonstrate that expanding access to long-acting reversible contraceptives to lower income women creates positive selection in the health of the children being born, reducing the rates of extremely preterm births and infant mortality. My most conservative estimates suggest reductions of 1.1 extremely preterm births and 1.1 infant deaths per 1,000 births, with the largest reduction in deaths due to Sudden Infant Death Syndrome. This suggests that expanding contraceptive access could help close the infant mortality gap between the U.S. and other leading economies.

Note:
Funding Information: This work has been supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD101480 and P2C-HD06613).

Conflict of Interests: No competing interests to declare.

Keywords: Contraceptive Access, Infant Mortality, Preterm Birth; Family Planning

JEL Classification: J13, I18, I12

Suggested Citation

Flynn, James, Can Expanding Contraceptive Access Reduce Adverse Infant Health Outcomes? (October 19, 2023). Available at SSRN: https://ssrn.com/abstract=4408753 or http://dx.doi.org/10.2139/ssrn.4408753

James Flynn (Contact Author)

Miami University of Ohio - Richard T. Farmer School of Business Administration ( email )

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
128
Abstract Views
671
Rank
422,162
PlumX Metrics